Cargando…
Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502489/ https://www.ncbi.nlm.nih.gov/pubmed/37712188 http://dx.doi.org/10.5009/gnl230338 |
| _version_ | 1785106333112991744 |
|---|---|
| author | Choi, Hyun Ho |
| author_facet | Choi, Hyun Ho |
| author_sort | Choi, Hyun Ho |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10502489 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105024892023-09-16 Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance? Choi, Hyun Ho Gut Liver Editorial Editorial Office of Gut and Liver 2023-09-15 2023-09-15 /pmc/articles/PMC10502489/ /pubmed/37712188 http://dx.doi.org/10.5009/gnl230338 Text en Copyright © Gut and Liver. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Choi, Hyun Ho Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance? |
| title | Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance? |
| title_full | Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance? |
| title_fullStr | Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance? |
| title_full_unstemmed | Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance? |
| title_short | Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance? |
| title_sort | is tegoprazan-based triple therapy effective in regions with high rates of clarithromycin resistance? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502489/ https://www.ncbi.nlm.nih.gov/pubmed/37712188 http://dx.doi.org/10.5009/gnl230338 |
| work_keys_str_mv | AT choihyunho istegoprazanbasedtripletherapyeffectiveinregionswithhighratesofclarithromycinresistance |